Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover comparison of salmeterol via HandiHaler 2 versus Serevent Diskus in COPD
2004-005238-37Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of salmeterol in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Forced expiratory volume in one second (FEV1). Started Jun 2005; status: completed.
02
Drugs
salmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2004-005238-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005238-37.